BTAIVSVBIO• 7 Days (Normalized)
BTAI vs VBIO (BioXcel Therapeutics Inc. vs Valion Bio Inc.)
Showing Closing Date Range from Sep, 07 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
+4.88%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
VBIO Performance $2.1
-16%
Valion Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
+20.88%
BTAI outperforming by 20.88%
BTAIVBIO
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI VBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | BTAI Price | BTAI Gain (%) | VBIO Price | VBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $0.05 | +4.88% | $2.10 | -16.00% | +20.88% |
| Sep 11, 2026 | $0.05 | +18.60% | $2.26 | -9.60% | +28.20% |
| Sep 10, 2026 | $0.05 | +16.28% | $2.20 | -12.00% | +28.28% |
| Sep 09, 2026 | $0.05 | +9.30% | $2.40 | -4.00% | +13.30% |
| Sep 08, 2026 | $0.04 | +0.00% | $2.50 | +0.00% | +0.00% |